Literature DB >> 20804675

Long-term survivors of adult rhabdomyosarcoma of maxillary sinus following multimodal therapy: case reports and literature reviews.

Tsung-Han Wu1, Jen-Seng Huang, Hung-Ming Wang, Cheng-Hsu Wang, Kun-Yun Yeh.   

Abstract

Rhabdomyosarcoma of the maxillary sinus is uncommon in adults. The clinical course and appropriate treatment strategy for the disease remains to be elucidated. This article describes two adult patients with rhabdomyosarcoma of the maxillary sinus who achieved long-term survival after undergoing multimodal therapy. We also reviewed the literature regarding 23 patients who were 15 years of age or older and had rhabdomyosarcoma of the maxillary sinus and were treated between 1950 and 2000. Results of our analysis suggest that multimodal therapy may become the mainstay treatment for adult rhabdomyosarcoma of the maxillary sinus. We believe that adequate surgical procedures, planned radiotherapy, aggressive chemotherapeutic agents and the best supportive care for complications may improve the prognosis of patients with this disease.

Entities:  

Mesh:

Year:  2010        PMID: 20804675

Source DB:  PubMed          Journal:  Chang Gung Med J        ISSN: 2072-0939


  4 in total

1.  Adult Rhabdomyosarcoma of Ethmoid Sinus Recurring as an Orbital Mass.

Authors:  Bahram Eshraghi; Kambiz Ameli; Pasha Anvari
Journal:  J Clin Diagn Res       Date:  2016-04-01

2.  Adult Sinonasal Rhabdomyosarcoma With Spinal Metastasis: A Case Report and Review of the Literature.

Authors:  Abdulaziz K Alaraifi; Raghad K Alsalamah; Abdulaziz A Alsalem; Abdul Latif Khan; Mohammed Elkrim
Journal:  Cureus       Date:  2022-06-12

3.  One-year survivor of adult alveolar rhabdomyosarcoma of the maxillary sinus with orbital extension: Case report.

Authors:  Jin-Ho Joo; Ji Sang Han; Shin-Myeong Choi; In-Ki Park; Jae-Ho Shin
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

Review 4.  Alveolar rhabdomyosarcoma of the vulva in an adult: a case report and literature review.

Authors:  Weihua He; Yue Jin; Xinhui Zhou; Ke Zhou; Rong Zhu
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.